{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T20:43:00Z","timestamp":1762375380880,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.ghir.2009.12.001","type":"journal-article","created":{"date-parts":[[2009,12,31]],"date-time":"2009-12-31T04:17:11Z","timestamp":1262233031000},"page":"156-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Marked reductions in bioactive insulin-like growth factor I (IGF-I) during hemodialysis"],"prefix":"10.1016","volume":"20","author":[{"given":"Per","family":"Ivarsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida","family":"Tietze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Sandahl","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Flyvbjerg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Frystyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2009.12.001_bib1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1053\/j.ajkd.2005.05.031","article-title":"Malnutrition in hemodialysis patients: what therapy?","volume":"46","author":"Bossola","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ghir.2009.12.001_bib2","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00467-006-0020-y","article-title":"Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement","volume":"21","author":"Mahan","year":"2006","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ghir.2009.12.001_bib3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00467-004-1713-8","article-title":"Growth hormone resistance in uremia, a role for impaired JAK\/STAT signaling","volume":"20","author":"Rabkin","year":"2005","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ghir.2009.12.001_bib4","first-page":"3","article-title":"Insulin-like growth factors and their binding proteins: biological actions","volume":"16","author":"Jones","year":"1995","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2009.12.001_bib5","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1046\/j.1523-1755.1999.00798.x","article-title":"Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure","volume":"56","author":"Frystyk","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.ghir.2009.12.001_bib6","first-page":"20","article-title":"Protein catabolism in sham-hemodialysis: the effect of different membranes","volume":"38","author":"Gutierrez","year":"1992","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.ghir.2009.12.001_bib7","doi-asserted-by":"crossref","first-page":"E107","DOI":"10.1152\/ajpendo.2002.282.1.E107","article-title":"Hemodialysis stimulates muscle and whole body protein loss and alters substrate oxidation","volume":"282","author":"Ikizler","year":"2002","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2009.12.001_bib8","first-page":"284","article-title":"Effect of hemodialysis on protein synthesis","volume":"54","author":"Lofberg","year":"2000","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.ghir.2009.12.001_bib9","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1111\/j.1523-1755.2004.00647.x","article-title":"The effect of dialysis dose and membrane flux on nutritional parameters in hemodialysis patients: results of the HEMO study","volume":"65","author":"Rocco","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.ghir.2009.12.001_bib10","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1681\/ASN.2006111207","article-title":"Growth hormone treatment during hemodialysis in a randomized trial improves nutrition, quality of life, and cardiovascular risk","volume":"18","author":"Feldt-Rasmussen","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ghir.2009.12.001_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/ajcn\/52.1.39","article-title":"IGF-I, a marker of undernutrition in hemodialysis patients","volume":"52","author":"Jacob","year":"1990","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ghir.2009.12.001_bib12","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/sj.ejcn.1602373","article-title":"Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?","volume":"60","author":"Axelsson","year":"2006","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.ghir.2009.12.001_bib13","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1172\/JCI0215449","article-title":"Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients","volume":"110","author":"Pupim","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ghir.2009.12.001_bib14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/BF03348913","article-title":"Insulin-like growth factor I values in patients on maintenance hemodialysis: relationship to growth hormone and albumin levels","volume":"16","author":"Caufriez","year":"1993","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.ghir.2009.12.001_bib15","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/ndt\/16.3.590","article-title":"Haemodialysis with the biocompatible high permeability AN-69 membrane does not alter plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3","volume":"16","author":"Bohe","year":"2001","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.ghir.2009.12.001_bib16","first-page":"137","article-title":"Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?","volume":"6","author":"Lindgren","year":"1996","journal-title":"Growth Regul."},{"key":"10.1016\/j.ghir.2009.12.001_bib17","first-page":"169","article-title":"Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II","volume":"5","author":"Frystyk","year":"1995","journal-title":"Growth Regul."},{"key":"10.1016\/j.ghir.2009.12.001_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0014-5793(94)00602-4","article-title":"Free insulin-like growth factors (IGF-I and IGF-II] in human serum","volume":"348","author":"Frystyk","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ghir.2009.12.001_bib19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1210\/jc.2002-021349","article-title":"Free and total insulin-like growth factor (IGF]-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease","volume":"88","author":"Krassas","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2009.12.001_bib20","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1210\/jcem.87.1.8147","article-title":"Development and clinical evaluation of a novel immunoassay for the binary complex of IGF-I and IGF-binding protein-1 in human serum","volume":"87","author":"Frystyk","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2009.12.001_bib21","doi-asserted-by":"crossref","first-page":"E1149","DOI":"10.1152\/ajpendo.00410.2002","article-title":"A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum","volume":"284","author":"Chen","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2009.12.001_bib22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1530\/eje.1.02218","article-title":"Changes in bioactive IGF-I and IGF-binding protein-1 during an oral glucose tolerance test in patients with liver cirrhosis","volume":"155","author":"Chen","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2009.12.001_bib23","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1210\/jc.2004-0039","article-title":"Free rather than total circulating insulin-like growth factor-I determines the feedback on growth hormone release in normal subjects","volume":"90","author":"Chen","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2009.12.001_bib24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/bmj.1.6062.679","article-title":"Somatomedin in growth disorders and chronic renal insufficiency in children","volume":"1","author":"Schwalbe","year":"1977","journal-title":"Brit. Med. J."},{"key":"10.1016\/j.ghir.2009.12.001_bib25","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/0026-0495(81)90053-6","article-title":"Circulating somatomedin activity and sulfate levels in adults with normal and impaired kidney function","volume":"30","author":"Phillips","year":"1981","journal-title":"Metabolism"},{"key":"10.1016\/j.ghir.2009.12.001_bib26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/BF01453697","article-title":"Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia","volume":"5","author":"Blum","year":"1991","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ghir.2009.12.001_bib27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1530\/eje.1.02203","article-title":"Glycosaminoglycans increase levels of free and bioactive IGF-I in vitro","volume":"155","author":"M\u00f8ller","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2009.12.001_bib28","first-page":"872","article-title":"Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1], IGFBP-3, and IGF-I in insulin-dependent diabetes","volume":"79","author":"Brismar","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2009.12.001_bib29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ghir.2004.06.001","article-title":"Free insulin-like growth factors \u2013 measurements and relationships to growth hormone secretion and glucose homeostasis","volume":"14","author":"Frystyk","year":"2004","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2009.12.001_bib30","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1744-9987.2007.00491.x","article-title":"Plasma insulin is removed by hemodialysis: evaluation of the relation between plasma insulin and glucose by using a dialysate with or without glucose","volume":"11","author":"Abe","year":"2007","journal-title":"Ther. Apher Dial."},{"key":"10.1016\/j.ghir.2009.12.001_bib31","first-page":"271","article-title":"Role of growth hormone, insulin-like growth factor-I, and insulin-like growth factor binding proteins in the catabolic response to injury and infection","volume":"5","author":"Lang","year":"2002","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.ghir.2009.12.001_bib32","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1774-9979.2004.00194.x","article-title":"A comparison of bicarbonate hemodialysis, hemodiafiltration, and acetate-free biofiltration on cytokine production","volume":"8","author":"Higuchi","year":"2004","journal-title":"Ther. Apher Dial."},{"key":"10.1016\/j.ghir.2009.12.001_bib33","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1081\/JDI-120021154","article-title":"Effect of membrane composition on cytokine production and clinical symptoms during hemodialysis: a crossover study","volume":"25","author":"Singh","year":"2003","journal-title":"Renal Fail."},{"key":"10.1016\/j.ghir.2009.12.001_bib34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/00365599009180364","article-title":"Serum hormone levels in men with end stage renal disease","volume":"24","author":"Carlstrom","year":"1990","journal-title":"Scand. J. Urol. Nephrol."},{"key":"10.1016\/j.ghir.2009.12.001_bib35","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1210\/endo.138.3.5020","article-title":"Purification and characterization of the insulin-like growth factor-binding protein-1 phosphoform found in normal plasma","volume":"138","author":"Westwood","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2009.12.001_bib36","first-page":"551","article-title":"Acetate: inhibitor of growth Hormone hypersecretion in Diabetic and non-diabetic uremic subjects","volume":"99","author":"\u00d8rskov","year":"1982","journal-title":"Acta Endocrinol. Copenh."},{"key":"10.1016\/j.ghir.2009.12.001_bib37","first-page":"70","article-title":"Inhibition of arginine- and hypoglycemia-induced growth hormone release by acetate in dialysed patients","volume":"17","author":"Schmitz","year":"1982","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.ghir.2009.12.001_bib38","first-page":"717","article-title":"Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human","volume":"19","author":"Giustina","year":"1998","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2009.12.001_bib39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000187891","article-title":"IGF-I as an early indicator of malnutrition in patients with end- stage renal disease","volume":"67","author":"Sanaka","year":"1994","journal-title":"Nephron"}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637409001580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637409001580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:45:33Z","timestamp":1761086733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637409001580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S1096637409001580"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2009.12.001","relation":{},"ISSN":["1096-6374"],"issn-type":[{"type":"print","value":"1096-6374"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Marked reductions in bioactive insulin-like growth factor I (IGF-I) during hemodialysis","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2009.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}